High Falls Advisors, Inc Johnson & Johnson Transaction History

High Falls Advisors, Inc

$404 Million
Q2 2024

A detailed history of High Falls Advisors, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, High Falls Advisors, Inc holds 1,890 shares of JNJ stock, worth $293,838. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,890

Previous 1,890 -0.0%

Holding current value

$293,838

Previous $298,000 7.38%

% of portfolio

0.07%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $117,656 - $123,356	-758 Reduced 28.63%	1,890 $298,000
Q4 2023 Feb 15, 2024	SELL	$145.6 - $158.88 $16,016 - $17,476	-110 Reduced 3.99%	2,648 $415,000
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $77,719 - $87,065	-499 Reduced 15.32%	2,758 $429,000
Q2 2023 Aug 15, 2023	BUY	$154.35 - $166.11 $154 - $166	1 Added 0.03%	3,257 $539,000
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $151 - $180	1 Added 0.03%	3,256 $504,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $320,239 - $359,400	-1,999 Reduced 38.05%	3,255 $574,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $161 - $179	1 Added 0.02%	5,254 $858,000
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $33,638 - $37,202	-200 Reduced 3.67%	5,253 $933,000
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $8,065 - $9,159	51 Added 0.94%	5,453 $966,000
Q4 2021 Feb 15, 2022	BUY	$155.93 - $173.01 $1,091 - $1,211	7 Added 0.13%	5,402 $924,000
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $161 - $179	1 Added 0.02%	5,395 $871,000
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $51,671 - $55,426	-324 Reduced 5.67%	5,394 $889,000
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $71,330 - $79,443	466 Added 8.87%	5,718 $940,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $720,101 - $826,559	5,252 New	5,252 $826,000
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $737,135 - $807,761	-5,251 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $128 - $155	1 Added 0.02%	5,251 $738,000
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $7,112 - $9,855	-64 Reduced 1.2%	5,250 $688,000
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $51,000 - $58,576	-400 Reduced 7.0%	5,314 $775,000
Q3 2019 Nov 21, 2019	SELL	$126.95 - $142.14 $101,813 - $113,996	-802 Reduced 12.31%	5,714 $739,000
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $5,246 - $5,769	-40 Reduced 0.61%	6,516 $908,000
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $41,151 - $49,526	-335 Reduced 4.86%	6,556 $846,000
Q3 2018 Nov 16, 2018	SELL	$121.58 - $142.88 $126,443 - $148,595	-1,040 Reduced 13.11%	6,891 $952,000
Q2 2018 Aug 15, 2018	BUY	$119.4 - $131.76 $119 - $131	1 Added 0.01%	7,931 $962,000
Q4 2017 Feb 16, 2018	SELL	$131.22 - $143.62 $13,122 - $14,362	-100 Reduced 1.25%	7,930 $1.11 Million
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $1.04 Million - $1.09 Million	8,030	8,030 $1.04 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Falls Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on High Falls Advisors, Inc with notifications on news.

Account

High Falls Advisors, Inc Johnson & Johnson Transaction History